Priority Date: 15.06.11 (EP 20110305748)

POLYPEPTIDES ISOLATED FROM BREVIBACTERIUM AURANTIACUM AND THEIR USE FOR THE TREATMENT OF CANCER

  • Application ID: EP12729514
  • Status: GRANT OF PATENT INTENDED

Attorneys

no operation time available
1081.16
2 offices
active in Legal Services
no operation time available
Headquarter in Paris
Technology Transfer Office

Specialization

This patent has the IPC class C07 (ORGANIC CHEMISTRY) Cabinet Lavoix and Inserm Transfert are specialized in C07. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 15.06.2011 - Priority Date (EP 20110305748)
  • 20.12.2012 - Publication A1 (WO2012172074)
  • 23.04.2014 - Publication A1 (EP2721057)

IPC Classification